Trials / Completed
CompletedNCT03754413
Neuramis® Volume Lidocaine for Volume Augmentation in the Mid-Face
A Multicenter Randomized, Evaluator-Blinded, "No Treatment" Controlled Study to Evaluate the Effectiveness and Safety of Neuramis® Volume Lidocaine for Volume Augmentation in the Mid-Face
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 236 (actual)
- Sponsor
- Medy-Tox · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the effectiveness and safety of Neuramis® Volume Lidocaine for volume augmentation in the mid-face.
Detailed description
This is a multicenter, randomized, evaluator-blinded, "no-treatment" controlled study conducted in normal, healthy subjects. This study is anticipated to enroll approximately 236 male and/or female subjects between the ages of 20 to 75 years, inclusive, who desire volume augmentation to correct deficit in their mid-face volume.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | experimental | Neuramis® Deep Lidocaine |
| DRUG | comparator | No-treatment |
Timeline
- Start date
- 2018-05-29
- Primary completion
- 2020-03-09
- Completion
- 2020-03-09
- First posted
- 2018-11-27
- Last updated
- 2021-03-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03754413. Inclusion in this directory is not an endorsement.